Biotech Firm Headed by Wayne Channon, Former British Team Dressage Rider, Reports Development of Coronavirus Capsule to be Mailed, Self-Administered
2 years ago StraightArrow Comments Off on Biotech Firm Headed by Wayne Channon, Former British Team Dressage Rider, Reports Development of Coronavirus Capsule to be Mailed, Self-Administered
April 6, 2020
Wayne Channon, a former British team dressage rider, reported Monday that a biotechnology company he heads has developed a coronavirus vaccine pill that can be distributed through the mail and self-administered by patients.
In an interview on the U.S. business network CNBC, Wayne said that the firm Stabilitech located about 40 miles/64km south of London hopes to produce millions of the coronavirus vaccine capsules by Christmas.
He did not say whether the capsule had been approved for use against COVID-19.
Wayne, 61 years old, a successful entrepreneur and longtime secretary general of the International Dressage Riders Club, competed his Dutch-bred Lorenzo for Britain at the 2005 European Championships and the 2006 World Equestrian Games as well as the World Cup Final in Las Vegas in 2007.
“There is a very big difference between how this will be absorbed by your system and a normal injection,” he said.
The capsule is swallowed by a patient and goes into the intestines to produce a vaccine that will in turn produce an immunity. The capsule, he said, provides both mucosal immunity (mucous glands in the mouth and nose, for example) as well as blood-borne systemic immunity provided by injected vaccines.
He compared the ability of mailing the capsule to millions of people around the world who could then swallow it as against the same number of people lining up to be injected–the closeness of large numbers of people at medical centers and exposure to health care professionals.
“With this you don’t,” he said referring to the capsule, “This is as simple as sending out by Amazon, Ali Baba or the mail. It’s very straightforward.”